The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been down 0.34% at 8,345 points, as the bourse pulls back from yesterday’s record highs.

Gold continues to jump, with rising demand for haven assets following an escalation of tensions in Russia’s invasion of Ukraine. Bullion traded above $US2,640 an ounce after advancing by more than two per cent over the first two days of the week.

To the sectors, Industrials, Telecommunication, and Energy have all been down around 1%, followed by Discretionary, down 0.9%. Utilities has been the sole sector to gain ground, up 0.25%.

Company News

Amcor (ASX:AMC) has been down 0.7% on news it’s merging with Berry Global Group (NYSE:BERY). The two packaging giants will unite in an all-stock deal worth $13 billion. Berry shareholders will receive 7.25 Amcor shares for each Berry share held, valuing Berry at $73.59 per share, a significant premium over Berry’s recent trading price. 

Amcor has been $15.58.

PainChek (ASX:PCK) has been up 10.7% on news its applied for Food and Drug Administration (FDA) approval for its new PainChek Adult App. The application comes hot on the heels of completion of a US-based validation study.

PainChek has been 3.1 cents.

PWR Holdings (ASX:PWH) has been down 31% as investors reacted very negatively to the company’s trading update. Guidance says NPAT is expected to be down from $9.8 million to between $3.2 and 3.7 million.

PWR has been $6.20.

More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…